432 related articles for article (PubMed ID: 19233048)
1. The economics of treatment in early rheumatoid arthritis.
Bansback N; Marra CA; Finckh A; Anis A
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):83-92. PubMed ID: 19233048
[TBL] [Abstract][Full Text] [Related]
2. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
Yen JH
Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
[TBL] [Abstract][Full Text] [Related]
3. Economic consequences of established rheumatoid arthritis and its treatment.
Kavanaugh A
Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):929-42. PubMed ID: 17870036
[TBL] [Abstract][Full Text] [Related]
4. What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
March L; Lapsley H
Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):171-85. PubMed ID: 11358421
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.
van den Hout WB; Goekoop-Ruiterman YP; Allaart CF; de Vries-Bouwstra JK; Hazes JM; Kerstens PJ; van Zeben D; Hulsmans HM; de Jonge-Bok JM; de Sonnaville PB; Dijkmans BA; Breedveld FC
Arthritis Rheum; 2009 Mar; 61(3):291-9. PubMed ID: 19248130
[TBL] [Abstract][Full Text] [Related]
6. Now that we know what's BeSt, what is good value for the money?
Bansback N; Marra CA
Arthritis Rheum; 2009 Mar; 61(3):289-90. PubMed ID: 19248126
[No Abstract] [Full Text] [Related]
7. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2006 Mar; 45(3):325-31. PubMed ID: 16287927
[TBL] [Abstract][Full Text] [Related]
8. Drug management of early rheumatoid arthritis - 2008.
Sokka T; Mäkinen H
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
[TBL] [Abstract][Full Text] [Related]
9. Costs of rheumatoid arthritis in Hungary.
Péntek M; Kobelt G; Czirják L; Szekanecz Z; Poór G; Rojkovich B; Polgár A; Genti G; Kiss CG; Brodszky V; Májer I; Gulácsi L
J Rheumatol; 2007 Jun; 34(6):1437. PubMed ID: 17552071
[No Abstract] [Full Text] [Related]
10. [Rheumatoid arthritis: milestones in classification and treatment].
Fiehn C
Dtsch Med Wochenschr; 2011 Feb; 136(5):203-5. PubMed ID: 21271482
[TBL] [Abstract][Full Text] [Related]
11. Early rheumatoid arthritis -- is there a window of opportunity?
Cush JJ
J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
[TBL] [Abstract][Full Text] [Related]
12. Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents.
Ohinmaa AE; Thanh NX; Barnabe C; Martin L; Russell AS; Barr SG; Maksymowych WP
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1319-27. PubMed ID: 24470178
[TBL] [Abstract][Full Text] [Related]
13. Health economics: implications for novel antirheumatic therapies.
Kavanaugh A
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv65-9. PubMed ID: 16239392
[TBL] [Abstract][Full Text] [Related]
14. The pharmacoeconomics of newer therapeutics for rheumatic diseases.
Kavanaugh A
Rheum Dis Clin North Am; 2006 Feb; 32(1):45-56, viii. PubMed ID: 16504820
[TBL] [Abstract][Full Text] [Related]
15. Unmet needs in rheumatoid arthritis.
Bykerk V
J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
[TBL] [Abstract][Full Text] [Related]
16. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
Polinski JM; Mohr PE; Johnson L
Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
[TBL] [Abstract][Full Text] [Related]
17. Back to the future: the managed care approach to rheumatoid arthritis.
Sidorov J
Manag Care Interface; 2007 Jul; 20(7):28-30. PubMed ID: 17849731
[TBL] [Abstract][Full Text] [Related]
18. Economic consequences and potential benefits.
Fautrel B; Verstappen SM; Boonen A
Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):607-24. PubMed ID: 22137927
[TBL] [Abstract][Full Text] [Related]
19. Conventional disease-modifying antirheumatic drugs in early arthritis.
Sokka T; Hannonen P; Möttönen T
Rheum Dis Clin North Am; 2005 Nov; 31(4):729-44. PubMed ID: 16287594
[TBL] [Abstract][Full Text] [Related]
20. Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomes.
Keystone EC
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):594-601. PubMed ID: 17075598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
